Marksans Pharma Limited has informed the Exchange regarding a press release dated January 11, 2022, titled "Marksans Pharma Limited announces final approval for Cetirizine Hydrochloride Tablets 5 mg and 10mg from US FDA.".
Press Release Jan 11 2022
Filed with NSE ·
6ix hasn’t read this filing yet.
Marksans Pharma Limited on 6ix
Earlier from Marksans Pharma
- Press Release Dec 09 2021
- Press Release Nov 10 2021
- Press Release Aug 26 2021
- Press Release Aug 11 2021
- Press Release Jul 10 2021
Later from Marksans Pharma
- Press Release Feb 22 2022
- Press Release Apr 25 2022
- Press Release Jun 21 2022
- Press Release Jul 21 2022
- Press Release Aug 13 2022
Follow Marksans Pharma into a list and get an email when it puts out news.
Follow Marksans Pharma